FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2328153539> ?p ?o ?g. }

• W2328153539 endingPage "7315" @default.
• W2328153539 startingPage "7296" @default.
• W2328153539 abstract "Cdc7 serine/threonine kinase is a key regulator of DNA synthesis in eukaryotic organisms. Cdc7 inhibition through siRNA or prototype small molecules causes p53 independent apoptosis in tumor cells while reversibly arresting cell cycle progression in primary fibroblasts. This implies that Cdc7 kinase could be considered a potential target for anticancer therapy. We previously reported that pyrrolopyridinones (e.g., 1) are potent and selective inhibitors of Cdc7 kinase, with good cellular potency and in vitro ADME properties but with suboptimal pharmacokinetic profiles. Here we report on a new chemical class of 5-heteroaryl-3-carboxamido-2-substituted pyrroles (1A) that offers advantages of chemistry diversification and synthetic simplification. This work led to the identification of compound 18, with biochemical data and ADME profile similar to those of compound 1 but characterized by superior efficacy in an in vivo model. Derivative 18 represents a new lead compound worthy of further investigation toward the ultimate goal of identifying a clinical candidate." @default.
• W2328153539 created "2016-06-24" @default.
• W2328153539 creator A5005000224 @default.
• W2328153539 creator A5005794932 @default.
• W2328153539 creator A5008691829 @default.
• W2328153539 creator A5013685136 @default.
• W2328153539 creator A5015038759 @default.
• W2328153539 creator A5017344742 @default.
• W2328153539 creator A5018214424 @default.
• W2328153539 creator A5018226935 @default.
• W2328153539 creator A5019459764 @default.
• W2328153539 creator A5020948103 @default.
• W2328153539 creator A5021457170 @default.
• W2328153539 creator A5025261960 @default.
• W2328153539 creator A5031349619 @default.
• W2328153539 creator A5032186940 @default.
• W2328153539 creator A5034842909 @default.
• W2328153539 creator A5038055949 @default.
• W2328153539 creator A5040236379 @default.
• W2328153539 creator A5051084648 @default.
• W2328153539 creator A5053378496 @default.
• W2328153539 creator A5055242790 @default.
• W2328153539 creator A5057560316 @default.
• W2328153539 creator A5058402482 @default.
• W2328153539 creator A5059263766 @default.
• W2328153539 creator A5061445728 @default.
• W2328153539 creator A5062095629 @default.
• W2328153539 creator A5066657439 @default.
• W2328153539 creator A5068292360 @default.
• W2328153539 creator A5071929591 @default.
• W2328153539 creator A5074684776 @default.
• W2328153539 creator A5080881030 @default.
• W2328153539 creator A5083934929 @default.
• W2328153539 creator A5085619076 @default.
• W2328153539 creator A5087466175 @default.
• W2328153539 creator A5088097104 @default.
• W2328153539 creator A5088929149 @default.
• W2328153539 creator A5090008303 @default.
• W2328153539 creator A5091160977 @default.
• W2328153539 date "2010-09-27" @default.
• W2328153539 modified "2023-10-12" @default.
• W2328153539 title "Cdc7 Kinase Inhibitors: 5-Heteroaryl-3-Carboxamido-2-Aryl Pyrroles as Potential Antitumor Agents. 1. Lead Finding" @default.
• W2328153539 cites W1255890544 @default.
• W2328153539 cites W1973696157 @default.
• W2328153539 cites W1993143177 @default.
• W2328153539 cites W1994939144 @default.
• W2328153539 cites W2001442235 @default.
• W2328153539 cites W2012044526 @default.
• W2328153539 cites W2012172422 @default.
• W2328153539 cites W2015728503 @default.
• W2328153539 cites W2027163446 @default.
• W2328153539 cites W2029348638 @default.
• W2328153539 cites W2033346155 @default.
• W2328153539 cites W2036086205 @default.
• W2328153539 cites W2045077507 @default.
• W2328153539 cites W2048631643 @default.
• W2328153539 cites W2069618375 @default.
• W2328153539 cites W2071464010 @default.
• W2328153539 cites W2073444234 @default.
• W2328153539 cites W2081857093 @default.
• W2328153539 cites W2084197694 @default.
• W2328153539 cites W2106130068 @default.
• W2328153539 cites W2113152190 @default.
• W2328153539 cites W2143139841 @default.
• W2328153539 cites W2143786806 @default.
• W2328153539 cites W2170811501 @default.
• W2328153539 cites W2492111198 @default.
• W2328153539 cites W2951519462 @default.
• W2328153539 cites W2951869381 @default.
• W2328153539 doi "https://doi.org/10.1021/jm100504d" @default.
• W2328153539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20873740" @default.
• W2328153539 hasPublicationYear "2010" @default.
• W2328153539 type Work @default.
• W2328153539 sameAs 2328153539 @default.
• W2328153539 citedByCount "56" @default.
• W2328153539 countsByYear W23281535392012 @default.
• W2328153539 countsByYear W23281535392013 @default.
• W2328153539 countsByYear W23281535392014 @default.
• W2328153539 countsByYear W23281535392015 @default.
• W2328153539 countsByYear W23281535392016 @default.
• W2328153539 countsByYear W23281535392017 @default.
• W2328153539 countsByYear W23281535392018 @default.
• W2328153539 countsByYear W23281535392019 @default.
• W2328153539 countsByYear W23281535392020 @default.
• W2328153539 countsByYear W23281535392021 @default.
• W2328153539 countsByYear W23281535392022 @default.
• W2328153539 countsByYear W23281535392023 @default.
• W2328153539 crossrefType "journal-article" @default.
• W2328153539 hasAuthorship W2328153539A5005000224 @default.
• W2328153539 hasAuthorship W2328153539A5005794932 @default.
• W2328153539 hasAuthorship W2328153539A5008691829 @default.
• W2328153539 hasAuthorship W2328153539A5013685136 @default.
• W2328153539 hasAuthorship W2328153539A5015038759 @default.
• W2328153539 hasAuthorship W2328153539A5017344742 @default.
• W2328153539 hasAuthorship W2328153539A5018214424 @default.
• W2328153539 hasAuthorship W2328153539A5018226935 @default.
• W2328153539 hasAuthorship W2328153539A5019459764 @default.
• W2328153539 hasAuthorship W2328153539A5020948103 @default.

• next